IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q4 2025 Holdings

Filed 2026-02-17 | 19 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Heartflow Inc(HTFL)COM42238D107$362.9M12,448,15827.8%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$256.3M7,306,56619.6%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$212.7M8,508,64116.3%
Savara Inc(SVRA)COM805111101$106.1M17,600,6218.1%
Pharvaris N V(PHVS)COMN69605108$77.8M2,802,0816.0%
Solid Biosciences Inc(SLDB)COM NEW83422E204$44.6M7,911,6693.4%
Upstream BIO Inc(UPB)COM91678A107$36.1M1,329,5442.8%
X4 Pharmaceuticals Inc(XFOR)COM NEW98420X202$31.9M7,967,4542.4%
Dianthus Therapeutics Inc(DNTH)COM252828108$30.6M743,5922.3%
Kyverna Therapeutics Inc(KYTX)COM501976104$29.2M3,110,0002.2%
Annexon Inc(ANNX)COM03589W102$26.4M5,249,0692.0%
Rapid Micro Biosystems Inc(RPID)CLASS A COM75340L104$24.5M8,434,5601.9%
Cabaletta BIO Inc(CABA)COM12674W109$21.2M9,677,1251.6%
C4 Therapeutics Inc(CCCC)COM STK12529R107$13.7M7,171,9101.0%
Mersana Therapeutics Inc(MRSN)COM59045L205$10.0M346,5450.8%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$8.9M2,485,6380.7%
Tango Therapeutics Inc(TNGX)COM87583X109$5.8M653,4930.4%
Xilio Therapeutics Inc(XLO)COM98422T100$4.7M7,372,6860.4%
Newamsterdam Pharma Company*W EXP 99/99/999N62509117$2.3M99,9990.2%